K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 333.8 INR 1.46% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Net Margin
Kilitch Drugs (India) Ltd

8.3%
Current
8%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.3%
=
Net Income
125.8m
/
Revenue
1.5B

Net Margin Across Competitors

Country IN
Market Cap 5.4B INR
Net Margin
8%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 761.8B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 368.4B USD
Net Margin
17%
Country US
Market Cap 250.9B USD
Net Margin
19%
Country CH
Market Cap 208.8B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 158.6B GBP
Net Margin
13%
Country IE
Market Cap 155B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Kilitch Drugs (India) Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.3%
=
Net Income
125.8m
/
Revenue
1.5B
What is the Net Margin of Kilitch Drugs (India) Ltd?

Based on Kilitch Drugs (India) Ltd's most recent financial statements, the company has Net Margin of 8.3%.